Search

Your search keyword '"Sanai, Faisal"' showing total 531 results

Search Constraints

Start Over You searched for: Author "Sanai, Faisal" Remove constraint Author: "Sanai, Faisal"
531 results on '"Sanai, Faisal"'

Search Results

2. Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score

3. Global burden of metabolic dysfunction-associated liver disease, 2010 to 2021

4. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

6. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

8. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

9. Multisociety consensus recommendations on hepatitis delta virus infection.

10. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

12. WED-458 Low testing rates but high prevalence of hepatitis delta virus in Saudi Arabia

14. The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi Arabia.

15. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait

16. The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia.

17. Stigma in steatotic liver disease: A survey of patients from Saudi Arabia.

23. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024

24. Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt.

26. Antibiotic Exposure Concurrently with Anti-PD1 Blockade Therapy Reduces Overall Survival in Patients with Child–Pugh Class A Advanced Hepatocellular Carcinoma

27. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

28. Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4–infected patients with advanced liver fibrosis and decompensated cirrhosis

31. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

34. Long-term health and economic benefits of switching to tenofovir alafenamide versus continuing on entecavir in chronic hepatitis B patients with low-level viremia in Saudi Arabia

37. Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population

38. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

39. Long-term health and economic benefits of switching to tenofovir alafenamide versus continuing on entecavir in chronic hepatitis B patients with low level viremia in Saudi Arabia.

40. Antibiotic Exposure Concurrently with Anti-PD1 Blockade Therapy Reduces Overall Survival in Patients with Child–Pugh Class A Advanced Hepatocellular Carcinoma.

42. Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review.

45. Accuracy of International Guidelines for Identifying Significant Fibrosis in Hepatitis B e Antigen–Negative Patients With Chronic Hepatitis

49. Global multi-stakeholder endorsement of the MAFLD definition

50. Multicenter external validation of FIB-6: a novel, machine-learning, simple bedside score to rule out severe liver fibrosis and cirrhosis in patients with MAFLD

Catalog

Books, media, physical & digital resources